Proanthocyanidins can prevent the lectin-like oxidized LDL receptor-1 (LOX-1) from recognizing oxidized low-density lipoprotein LDL, which is a factor in the pathophysiology of arteriosclerosis. Here, OLR1 is linked to arteriosclerosis disorder.